Journal of Gastrointestinal Cancer

, Volume 45, Issue 4, pp 481–486 | Cite as

Primary Gastrointestinal Mantle Cell Lymphoma: A Retrospective Study

  • Lokanatha Dasappa
  • M. C. Suresh Babu
  • Nagesh T. Sirsath
  • T. M. Suresh
  • K. Govind Babu
  • Vishwanatha Sathyanarayna
  • K. N. Lokesh
  • K. C. Lakshmaiah
Original Research



Primary gastrointestinal tract mantle cell lymphoma is very rare. There is paucity of literature regarding natural history and outcome of this unusual entity.

Aims and Objectives

The aim of the present study was to analyze clinical profile, epidemiological parameters, and outcome of primary gastrointestinal mantle cell lymphoma patients treated at our institute.

Materials and Methods

This was a retrospective observational study of consecutive patients diagnosed with primary gastrointestinal mantle cell lymphoma at our institute between 2001 and 2012.


A total of seven patients, all males with a median age of 67.7 years, were diagnosed with primary gastrointestinal mantle cell lymphoma. Sites involved were the stomach, colon, and rectum. Blastoid and diffuse variants were observed in three patients each, and one patient had nodular pattern. Five patients received cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP) chemotherapy. Only one patient achieved complete remission and remained disease free for 21 months before being lost to follow up. The remaining four patients had inadequate response to CHOP chemotherapy with a median survival of 6 months. Cyclophosphamide, vincristine, prednisolone (CVP) was given to one patient in view of poor performance status. He had progressive disease and died after first cycle of chemotherapy. One patient is currently undergoing treatment and receiving rituximab with chemotherapy.


Primary gastrointestinal mantle cell lymphoma is highly aggressive with the Mantle Cell Lymphoma International Prognostic Index (MIPI) scores in high-risk group; survival is poor compared to nodal mantle cell lymphoma involving the gastrointestinal tract; patients respond poorly to CHOP chemotherapy. As majority of patients are elderly and not eligible for transplant, the use of rituximab in remission induction and maintenance should be considered to improve outcome of these patients.


Mantle Gastrointestinal CHOP Rituximab 


Conflict of Interest



  1. 1.
    Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60.PubMedCrossRefGoogle Scholar
  2. 2.
    Ghimire P, Guang-Yao W, Zhu L. Primary gastrointestinal lymphoma. World J Gastrenterol. 2011;17(6):697–707.CrossRefGoogle Scholar
  3. 3.
    Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19:1992–9.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Ferreri AJ, Montalban C. Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol. 2007;63:65–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Salar A, Juanpere N, Bellosillo B, et al. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol. 2006;30:1274–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Morton JE, Leyland MJ, Vaughan Hudson G, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer. 1993;67:776–82.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Weisenburger DD, Armitage JO. Mantle cell lymphoma—an entity comes of age. Blood. 1996;87:4483–94.PubMedGoogle Scholar
  9. 9.
    Bosch F, López-Guillermo A, Campo E, Ribera JM, Conde E. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer. 1998;82:567–75.PubMedCrossRefGoogle Scholar
  10. 10.
    Okazaki K. Multiple lymphomatous polyposis form is common but not specific for mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol. 2004;39:1023–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: morphology, immunophenotype and molecular features. J Gastrointest Oncol. 2012;3(3):209–25. doi:10.3978/j.issn.2078-6891.2012.024.PubMedCentralPubMedGoogle Scholar
  12. 12.
    Lai R, Medeiros LJ. Pathologic diagnosis of mantle cell lymphoma. Clin Lymphoma. 2000;1:197–206.PubMedCrossRefGoogle Scholar
  13. 13.
    Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-NelemansHoster HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111:558–65.PubMedCrossRefGoogle Scholar
  14. 14.
    Rummel MJ, Niederle N, Maschmeyer G, et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013;381(9873):1203–10.PubMedCrossRefGoogle Scholar
  15. 15.
    Kluin-Nelemans HC, Hoster E, Hermine O, et al. Treatment of older patients with mantle-cell lymphoma. N Engl J Med. 2012;367(6):520–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Ogura M. Current treatment strategy and new agents in mantle cell lymphoma. Int J Hematol. 2010;92:25–32.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee J, Kim WS, Kim K, et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res. 2007;31(3):359–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23(28):7050–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Ruskoné-Fourmestraux A, Delmer A, Lavergne A, et al. Multiple lymphomatous polyposis of the gastrointestinal tract: a prospective clinicopathologic study of 31 cases. Gastroenterology. 1997;112:7–16.PubMedCrossRefGoogle Scholar
  20. 20.
    Cestaro G, Deroa M, Vitiello C, Galloro G, Gentile M. Multiple lymphomatous polyposis with diffuse involvement of the gastrointestinal tract. Case report. G Chir. 2013;34(n. 5/6):173–5.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Cornes JS. Multiple lymphomatous polyposis of the gastrointestinal tract. Cancer. 1961;14:249–57.PubMedCrossRefGoogle Scholar
  22. 22.
    Kodama T, Ohshima K, Nomura K, et al. Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma. Histopathology. 2005;47:467–78.PubMedCrossRefGoogle Scholar
  23. 23.
    Ruskoné-Fourmestraux A, Audouin J. Primary gastrointestinal tract mantle cell lymphoma as multiple lymphomatous polyposis. Best Pract Res Clin Gastroenterol. 2010;24(1):35–42. doi:10.1016/j.bpg.2009.12.001.PubMedCrossRefGoogle Scholar
  24. 24.
    Michopoulos S, Petraki K, Matsouka C, Kastritis E, Chrysanthopoulou H, Dimopoulos MD. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract. J Clin Oncol. 2008;20:1555–7.CrossRefGoogle Scholar
  25. 25.
    Ming-Tzung L, Kuo Y-H, Chuah S-K, Chiu Y-C, Huang C-C, Wei-Chen Tai W, et al. Mantle cell lymphoma with diffuse gastrointestinal tract involvement: a case report. J Intern Med Taiwan. 2009;20:555–60.Google Scholar
  26. 26.
    Kim CH, Chun HJ, Kim TH, Jung W, Kim S, Hyun JJ, et al. Solitary primary gastric mantle cell lymphoma. Gut Liver. 2011;5:527–31.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Petranovic D, Pilcic G, Peitl M, Cubranic A, Valkovic T, Nacinovic AD, et al. Primary gastric mantle cell lymphoma. Hematol Rep. 2012;4(1):e1.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Tamura S, Ohkawauchi K, Yokoyama Y, Higashidani Y, Daibata M, Hiroi M, et al. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol. 2004;39(10):995–1000.PubMedCrossRefGoogle Scholar
  29. 29.
    Kikuchi T, Asano N, Noguchi T, et al. A case of primary gastric mantle cell lymphoma. Nihon Shokakibyo Gakkai Zasshi. 2009;106:1168–76.PubMedGoogle Scholar
  30. 30.
    Pitigoi D, Stoica V, Stoia R, Dobrea C, Becheanu G, Diculescu M. Gastric and colonic mantle cell lymphoma—incidental discovery. J Gastrointest Liver Dis. 2009;18:85–8.Google Scholar
  31. 31.
    Raderer M, Püspök A, Birkner T, Streubel B, Chott A. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn’s disease. Leuk Lymphoma. 2004;45:1459–62.PubMedCrossRefGoogle Scholar
  32. 32.
    Kella VKN, Constantine R, Parikh NS, Reed M, Cosgrove JM, Abo SM, et al. Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions—case report and review of literature. World J Surg Oncol. 2009;7:60.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Gulcu B, Ozer A, Nazlioglu HO, Ozturk E, Yilmazlar T. Perianal mantle cell lymphoma mimicking an external thrombosed hemorrhoid: a case report. J Med Case Rep. 2014;8:40.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Kelkitli E, Atay H, Yıldız L, Bektaş A, Turgut M. Mantle cell lymphoma mimicking rectal carcinoma. Case Rep Hematol. 2014;2014, 621017.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Bel Haj Salah M, Ben Brahim E, Zidi YS, Tangour M, Kilani H, Abdelmoula S, et al. Isolated primary gastric localization of a mantle cell lymphoma. Ann Pathol. 2010;30(4):321–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Bairey O, Ruchlemer R, Shpilberg O. Non-Hodgkin’s lymphomas of the colon. Isr Med Assoc J. 2006;8(12):832–5.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Lokanatha Dasappa
    • 1
  • M. C. Suresh Babu
    • 1
  • Nagesh T. Sirsath
    • 1
  • T. M. Suresh
    • 1
  • K. Govind Babu
    • 1
  • Vishwanatha Sathyanarayna
    • 1
  • K. N. Lokesh
    • 1
  • K. C. Lakshmaiah
    • 1
  1. 1.Department of Medical OncologyKidwai Memorial Institute of OncologyBangloreIndia

Personalised recommendations